CHI3L1 found in the cerebral spinal fluid (CSF) obtained from preclinical and prodromal cases of AD [33–35] has been suggested as a biomarker for discerning cognitively normal from mild cognitive impairment (MCI) individuals [25, 36, 37]. The gene discussed is CHI3L1; the disease is Alzheimer disease.